A dual-target SPR screening system for simultaneous ligand discovery of SARS-CoV-2 spike protein and its receptor ACE2 from Chinese herbs
Journal of Pharmaceutical and Biomedical Analysis · 2024
DOI: 10.1016/j.jpba.2024.116142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2024. Verfasst von Ying Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Pharmacy, School of Pharmacy, Naval Medical University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Spike Glycoprotein, Coronavirus, Surface Plasmon Resonance, Drugs, Chinese Herbal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Traditional Chinese Medicine (TCM) is a supremely valuable resource for the development of drug discovery. Few methods are capable of hunting for potential molecule ligands from TCM towards more than one single protein target. In this study, a novel dual-target surface plasmon resonance (SPR) biosensor was developed to perform targeted compound screening of two key proteins involved in the cellular invasion process of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): the spike (S) protein receptor binding domain (RBD) and the angiotensin-converting enzyme 2 (ACE2). The screening and identification of active compounds from six Chinese herbs were conducted taking into consideration the multi-component and multi-target nature of Traditional Chinese Medicine (TCM). Puerarin from Radix Puerariae Lobatae was discovered to exhibit specific binding affinity to both S protein RBD and ACE2. The results highlight the efficiency of the dual-target SPR system in drug screening and provide a novel approach for exploring the targeted mechanisms of active components from Chinese herbs for disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Pharmacy, School of Pharmacy, Naval Medical University, Shanghai 200433, China.
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Naval Medical University, Shanghai 200433, China; Department of Pharmaceutical Analysis, School of Pharmacy, Naval Medical University,…
- Suzhou Innovation Center of Shanghai University, Suzhou 215127, China.
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Naval Medical University, Shanghai 200433, China; Center for Instrumental Analysis, School of Pharmacy, Naval Medical University, Shang…
- Department of Biochemical Pharmacy, School of Pharmacy, Naval Medical University, Shanghai 200433, China; Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Naval Medical University, Sha…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Wang, D., Wang, X., Ma, H., Liu, Y., Hong, Z., Zhu, Z., Chen, X., Lv, D., Cao, Y., & Chai, Y. (2024). A dual-target SPR screening system for simultaneous ligand discovery of SARS-CoV-2 spike protein and its receptor ACE2 from Chinese herbs. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.116142
Vancouver
Zhang Y, Wang D, Wang X, Ma H, Liu Y, Hong Z, et al. A dual-target SPR screening system for simultaneous ligand discovery of SARS-CoV-2 spike protein and its receptor ACE2 from Chinese herbs. Journal of Pharmaceutical and Biomedical Analysis. 2024. doi:10.1016/j.jpba.2024.116142
BibTeX
@article{Zhang2024,
author = {Zhang, Ying and Wang, Dongyao and Wang, Xiying and Ma, Huilin and Liu, Yue and Hong, Zhanying and Zhu, Zhenyu and Chen, Xiaofei and Lv, Diya and Cao, Yan and Chai, Yifeng},
title = {A dual-target SPR screening system for simultaneous ligand discovery of SARS-CoV-2 spike protein and its receptor ACE2 from Chinese herbs},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2024},
doi = {10.1016/j.jpba.2024.116142}
}
EUVIMED